000			02066 a2200541 4500
005			20250515023133.0
264		0	_c20060829
008			200608s 0 0 eng d
022			_a1537-1891
024	7		_a10.1016/j.vph.2006.03.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aMcGillicuddy, Fiona C
245	0	0	_aTGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. _h[electronic resource]
260			_bVascular pharmacology _cJun 2006
300			_a469-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aCells, Cultured
650	0	4	_aCoronary Restenosis _xprevention & control
650	0	4	_aCoronary Vessels _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFatty Acids, Monounsaturated _xpharmacology
650	0	4	_aFluvastatin
650	0	4	_aGene Expression Regulation
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aIndoles _xpharmacology
650	0	4	_aMAP Kinase Signaling System
650	0	4	_aMale
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aMyocytes, Smooth Muscle _xdrug effects
650	0	4	_aPhosphorylation
650	0	4	_aPyridines _xpharmacology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aThrombospondin 1 _xgenetics
650	0	4	_aTransforming Growth Factor beta _xpharmacology
650	0	4	_aTransforming Growth Factor beta1
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xmetabolism
700	1		_aO'Toole, Daniel
700	1		_aHickey, Jennifer A
700	1		_aGallagher, William M
700	1		_aDawson, Kenneth A
700	1		_aKeenan, Alan K
773	0		_tVascular pharmacology _gvol. 44 _gno. 6 _gp. 469-75
856	4	0	_uhttps://doi.org/10.1016/j.vph.2006.03.002 _zAvailable from publisher's website
999			_c16229013 _d16229013